Valerie Shiu, MD
MOHS-Micrographic Surgery · San Antonio, TXNPI 1194110874
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,011, 2.0 times the $503 reported in 2019.
Across 40 payments — averaging $60.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$382
- AbbVie$341
- Regeneron Healthcare Solutions, Inc.$339
- UCB, Inc.$231
- Mimedx Group, Inc.$194
- E.r. Squibb & Sons, L.L.C.$144
- plus $787 from 12 others
What the payments were for
- Food & beverage$2,34197%
- Education$773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 7 | $382 |
| AbbVie | 3 | $341 |
| Regeneron Healthcare Solutions, Inc. | 6 | $339 |
| UCB, Inc. | 2 | $231 |
| Mimedx Group, Inc. | 1 | $194 |
| E.r. Squibb & Sons, L.L.C. | 2 | $144 |
| Organon | 4 | $118 |
| Verrica Pharmaceuticals Inc. | 1 | $113 |
| Incyte Corporation | 2 | $105 |
| Dermavant Sciences, Inc. | 1 | $94 |
| Genentech USA, Inc. | 2 | $94 |
| Sanofi | 1 | $94 |
| Sun Pharmaceutical Industries Inc. | 3 | $70 |
| Lilly USA, LLC | 1 | $30 |
| Kerecis Limited | 1 | $20 |
| Novartis | 1 | $19 |
| Krystal Biotech Inc | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,418 in reported general payments places this provider in the 55th percentile of 109 mohs-micrographic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 21 | $200 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $107 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $70 |
| Cephalexin | 16 | $41 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in San Antonio
- Ryan O QuinnSan Antonio$167K
- Christina Steinmetz-RodriguezSan Antonio$10K
- Byron LimmerSan Antonio$4K
- James NeinerSan Antonio$4K
- Aaron FarbergRockwall$1.5M
- Suneel ChilukuriBellaire$288K
- Paul FriedmanHouston$131K
- Brent SpencerFrisco$45K
- Julie CroleyThe Woodlands$30K
- Kayla McNieceBellaire$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.